These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6347666)

  • 21. Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in toad bladder.
    Perrone RD; Schwartz JH; Bengele HH; Dale SL; Melby JC; Alexander EA
    Am J Physiol; 1981 Nov; 241(5):E406-9. PubMed ID: 6795931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct vascular effects of 19-hydroxyandrostenedione.
    Mikami H; Ogihara T; Ohde H; Katahira K; Kohara K; Kumahara Y
    Methods Find Exp Clin Pharmacol; 1989 Apr; 11(4):241-8. PubMed ID: 2755272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low plasma 19-hydroxyandrostenedione levels in patients with aldosterone-producing adenoma.
    Morita H; Mune T; Yasuda K; Yamakita N; Miyazaki S; Miura K
    Endocr J; 1993 Feb; 40(1):89-97. PubMed ID: 7951501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of clonidine on renin and aldosterone of hypertensive patients.
    Salvetti A; Pedrinelli R; Cavasinni L; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):50-6. PubMed ID: 6989768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for age-related change in plasma 19-hydroxyandrostenedione.
    Higuchi K; Ogo A; Maki T; Haji M; Takayanagi R; Ohashi M; Nawata H; Kato K; Ibayashi H
    Endocrinol Jpn; 1989 Dec; 36(6):881-5. PubMed ID: 2561277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of potassium loading in normal man on dopaminergic control of mineralocorticoids and renin release.
    Witzgall H; Behr J
    J Hypertens; 1986 Apr; 4(2):201-5. PubMed ID: 3519763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in adrenalectomized rat.
    Perrone RD; Bengele HH; Dale SL; Melby JC; Alexander EA
    Am J Physiol; 1982 May; 242(5):E305-8. PubMed ID: 7081431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma aldosterone and corticosterone responses to adrenocorticotropin, angiotensin, potassium, and stress in spontaneously hypertensive rats.
    Sowers J; Tuck M; Asp ND; Sollars E
    Endocrinology; 1981 Apr; 108(4):1216-21. PubMed ID: 6258898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertensinogenic potencies of aldosterone and deoxycorticosterone in the rat.
    Komanicky P; Melby JC
    Hypertension; 1982; 4(1):140-5. PubMed ID: 7061121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosterone methyloxidase II activity during hemodialysis.
    Zager PG; Spalding CT; Frey HJ; Brittenham MC
    J Lab Clin Med; 1987 Feb; 109(2):178-83. PubMed ID: 3543178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periodic hypokalaemic paralysis, adrenal adenoma, and normal colonic transport of sodium and potassium.
    Richards P; Jones MB; Peart WS
    Gut; 1973 Jun; 14(6):478-84. PubMed ID: 4719216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
    Baxter JD; Schambelan M; Matulich DT; Spindler BJ; Taylor AA; Bartter FC
    J Clin Invest; 1976 Sep; 58(3):579-89. PubMed ID: 182723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrolyte and hormonal effects of deoxycorticosterone acetate in young pigs.
    Grekin RJ; Terris JM; Bohr DF
    Hypertension; 1980; 2(3):326-32. PubMed ID: 6993359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escape from the sodium-retaining action of intrarenal angiotensins II and III in the conscious dog.
    Dickstein GM; Woodson JF; Lamb NE; Rose CE; Peach MJ; Carey RM
    Endocrinology; 1985 Nov; 117(5):2160-9. PubMed ID: 4042980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of sodium transport by toad skin incubated with natural derivatives of corticosterone and deoxycorticosterone.
    Beauwens R; Birmingham M; Crabbé J
    J Endocrinol; 1983 Nov; 99(2):293-300. PubMed ID: 6418847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hypertensinogenic activity of 19-nor-deoxycorticosterone in the adrenalectomized spontaneously hypertensive rat.
    Gorsline J; Morris DJ
    J Steroid Biochem; 1985 Oct; 23(4):535-6. PubMed ID: 3906279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.
    New MI; Levine LS; Biglieri EG; Pareira J; Ulick S
    J Clin Endocrinol Metab; 1977 May; 44(5):924-33. PubMed ID: 870517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
    Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
    Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
    Burton G; Galigniana M; De Lavallaz S; Brachet-Cota AL; Sproviero EM; Ghini AA; Lantos CP; Damasco MC
    Mol Pharmacol; 1995 Mar; 47(3):535-43. PubMed ID: 7700251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.